CSI Market
Sign In | Register

Glucotrack Inc (GCTK) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access GCTK quarterly Cash Flow →
The data below summarizes Glucotrack Inc's cash flow activity from Dec 31 2021 to Dec 31 2025, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-19.39
Depreciation & amortization0.04
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.02
Share-based Compensation0.21
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Linkage Difference On Principal Of Loans From Stockholders-
Increase Decrease In Operating Lease Rightofuse Assets-
Equity Issuance Costs-
Issuance Of Restricted Shares As Compensation To Board Of Directors0.12
Gain Loss Related To Litigation Settlement-
Gain Loss On Equity Issuance-
Amortization Of Original Issue Discount Related To Promissory Note-
Derivative Gain Loss On Derivative Net-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable0.33
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital-0.12
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities3.55
Discontinued operations0.00
Net Cash flow from Operating Activities-15.24
Investing Activities
Capital Expenditures-0.10
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Increase In Longterm Restricted Cash-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.10
Financing Activities
Short-term debt Net3.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock3.38
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Common Stock Net Of Issuance Costs-
Proceeds Allocated To Series C Preferred Stock Net Of Cash Issuance Expenses-
Proceeds Allocated To Series C Warrants Net Of Cash Issuance Expenses-
Proceeds Received From Underwritten Public Offering-
Net Proceeds Received From Underwritten Public Offering10.67
Proceeds From Issuance Of Convertible Promissory Note-
Proceeds From Issuance Of Convertible Promissory Note One-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities17.04
Effect of exchange rate on cash flow0.05
Discontinued operations0.00
Free Cash Flow-15.34
Total Cash Flow1.76
4 historic quarters locked

Sign in to unlock the full Glucotrack Inc cash flow history.

Sign In Create Free Account

About Glucotrack Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 30, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-013656

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License